A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistanceDeyin Xing(Harvard University), Sandra Oršulić(University of California, Los Angeles)Proceedings of the National Academy of SciencesApril 28, 200510.1073/pnas.0502256102Cited by 99SaveCiteExport RISWatch citationsRelated PapersSphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer|Oncotarget|2015|59INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer|npj Precision Oncology|2024|39Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma|Science Advances|2024|26